Related Experiment Video
Updated: Nov 25, 2025
26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
18.5K
Autoimmune encephalitis in children and adolescents.
1Epilepsy Center Bethel, Krankenhaus Mara, Maraweg 17-21, 33617 Bielefeld, Germany.
Neurological Research and Practice
|December 16, 2020
Summary
Autoimmune encephalitides are diagnosed by detecting autoantibodies. Pediatric autoimmune encephalitis management mirrors adult approaches, with immunotherapy being key.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Autoimmune encephalitides (AE) are increasingly recognized neurological disorders.
- Antibodies targeting neural and glial antigens are crucial biomarkers.
- AE pathogenesis, tumor association, and treatment response are linked to antibody type.
Purpose of the Study:
- To discuss the relevance and management of antibody-associated encephalitides in children.
- To highlight diagnostic approaches and therapeutic strategies for pediatric AE.
Main Methods:
- Diagnosis relies on identifying autoantibodies in serum and cerebrospinal fluid.
- N-methyl-D-aspartate receptor (NMDAR) antibodies are most common.
- Treatment involves immunotherapy, including steroids, apheresis, and IVIg as first-line, with rituximab or cyclophosphamide as second-line.
Main Results:
- Patients with surface antibodies generally respond well to immunotherapy.
- Cases with intracellular antibodies show less favorable responses to treatment.
- Antibody-associated AE can present as complex neuropsychiatric conditions.
Conclusions:
- Pediatric autoimmune encephalitis management is largely consistent with adult protocols.
- Immunotherapy is the primary treatment modality for AE.
